기본 정보
- CAS
1162664-19-8- 표준 SMILES
O.O=C(NN1C(=O)[C@@H]2[C@@H]3C=C[C@@H]([C@H]4C[C@@H]34)[C@@H]2C1=O)c1ccc(C(F)(F)F)cc1- InChIKey
QRHXYGPOQKLBJP-NPIFKJBVSA-N- 분자식
- C19H17F3N2O4
- 평균 분자량
- 394.3 g/mol
개요
Tecovirimat is an antiviral prescription medicine approved by the U.S. Food and Drug Administration(FDA) for the treatment of smallpox in adults and children. (Smallpox is a disease caused by the variola virus, a member of a group of viruses called Orthopoxvirus. Since 1980, smallpox has been considered eradicated worldwide.)
이름 및 식별자
- 우선 이름
- Tecovirimat monohydrate
- IUPAC
- N-[(1R,2R,6S,7S,8S,10R)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide;hydrate
- 영어명
- Tecovirimat Monohydrate
- 분자식
- C19H15F3N2O3.H2O
- 분자량
- 394.35
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
1162664-19-8- PubChem CID
- 90479083
- ChEMBL
CHEMBL5315121- UNII
- SB96YO2BR8
물성
구조 계산 물성
- 극성 표면적
- 67.5 Ų
- 수소 결합 공여자 수
- 2
- 수소 결합 수용자 수
- 7
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 28
- 형식 전하
- 0
- 복잡도
- 705
실험 및 물리화학적 성질
화학 및 산업
약리 정보
FDA Pharmacological Classification
TECOVIRIMAT MONOHYDRATE
Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]; Cytochrome P450 2C19 Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]
MeSH Pharmacological Classification
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
공급사13 곳
관련 반응
화합물 노트
불러오는 중…